688068:SHA
Beijing Hotgen Biotech Co Ltd
CNÂ¥84.54
arrow_downward
-1.10%(-0.94) 1D
Oct 9, 3:00:02 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 688068...
Open
CNÂ¥85.00
High
CNÂ¥85.54
Low
CNÂ¥80.00
Mkt. cap
7.84B
Avg. vol.
2.62M
Volume
3.17M
52-wk high
CNÂ¥214.78
52-wk low
CNÂ¥73.44
EPS
-CNÂ¥3.00
No. of employees
1K
Open
CNÂ¥85.00
High
CNÂ¥85.54
Low
CNÂ¥80.00
Mkt. cap
7.84B
Avg. vol.
2.62M
Volume
3.17M
52-wk high
CNÂ¥214.78
52-wk low
CNÂ¥73.44
EPS
-CNÂ¥3.00
No. of employees
1K
News stories
From web sources and news partners
Simply Wall Street
·
1 hour ago
SolarEdge Technologies (SEDG) Appoints Gokul Krishnan To Lead North America Growth
Simply Wall Street
·
51 minutes ago
GLOBALFOUNDRIES (GFS) Unveils FDX Fusion As Dresden And AI Packaging Plans Advance
Simply Wall Street
·
1 hour ago
Lineage (LINE) Following Its BSF Extension And The Undervalued Narrative
Yahoo Finance
·
7 hours ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
Profile
Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification.
Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia
About Beijing Hotgen Biotech Co Ltd